Mucolipidosis type IV and the mucolipins

Biochemical Society Transactions

Volumn 38, Issue 6, 2010, Pages 1432-1435

  Bach, Gideon ^a   Zeevi, David A ^a   Frumkin, Ayala ^a   Kogot Levin, Aviram ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Endocytosis; Mucolipidosis type IV (MLIV); Mucolipin; Protein protein interaction; Transient receptor potential mucolipin (TRPML)

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MUCOLIPIN; MUCOLIPIN 1; MUCOLIPIN 2; MUCOLIPIN 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; ISOPROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M;

CELLULAR DISTRIBUTION; CONFERENCE PAPER; ENDOCYTOSIS; ENDOSOME; GENE MUTATION; LYSOSOME; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ARTICLE; GENETICS; HUMAN; METABOLISM; MUTATION;

HUMANS; MUCOLIPIDOSES; MUTATION; PROTEIN ISOFORMS; TRPM CATION CHANNELS;

EID: 78649724359     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0381432     Document Type: Conference Paper

References (70)

1. Berman, E.R., Livni, N., Shapira, E., Merin, S. and Levij, I.S. (1974) Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J. Pediatr. 84, 519-526
2. Altarescu, G., Sun, M., Moore, D.R., Smith, J.A., Wiggs, E.A., Solomon, B.I., Patronas, N.S., Frei, K.P., Gupta, S., Kaneski, C.R. et al. (2002) The neurogenetics of mucolipidosis type IV. Neurology 59, 306-313
3. Bach, G. (2002) Mucolipidosis type IV: a review. Mol. Genet. Metab. 73, 197-203
4. Bach, G. (2005) Mucolipin 1: endocytosis and cation channel. Pflügers Arch. 451, 313-317
5. Chitayat, D., Meunier, C.M., Hodgkinson, K.A., Silver, K., Flanters, M., Anderson, I.J., Little, J.M., Whiterman, D.A.H. and Carpenter, S. (1991) Mucolipidosis type IV: clinical manifestations and natural history. Am. J. Med. Genet. 41, 313-318
6. Casteels, I., Taylor, D.S.I., Lake, B.D., Spalton, D.J. and Bach, G. (1992) Mucolipidosis type IV: presentation of a mild variant. Ophthalmol. Pediat. Genet. 13, 205-210
7. Reiss, S., Sheffer, R., Merin, S., Luder, A. and Bach, G. (1993) Mucolipidosis type IV: A late onset and mild form. Am. J. Med. Genet. 47, 392-394
8. Bargal, R., Avidan, N., Ben Asher, E., Olender, Z., Zeigler, M., Frumkin, A., Raas-Rothschild, A., Glusman, G., Lancet, D. and Bach, G. (2000) Identification of the gene causing mucolipidosis type IV. Nat. Genet. 26, 118-123
9. Bassi, M.T., Manzoni, M., Monti, E., Pizzo, M.T., Ballabio, A. and Borsani, G. (2000) Cloning of the gene encoding a novel integral membrane protein, mucolipin, and identification of the two major founder mutations causing mucolipidosis type IV. Am. J. Hum. Genet 67, 1110-1120
10. Sun, M., Goldin, E., Stahl, S., Falardeaum, J.L., Kennedy, J.C., Acierno, J.S., Bove, C., Kaneski, C.R., Nagle, J., Bromely, M.C. et al. (2000) Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 9, 2471-2478
11. Slaugenhaupt, S.A., Acienro, J.S., Helbing, L.A., Bove, C., Goldin, E., Bach, G., Schiffmann, R. and Gusella, J.F. (1999) Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes. Am. J. Hum. Genet. 65, 773-778
12. Raas-Rothschild, A., Bargal, R., DellaPergola, S., Zeigler, M. and Bach, G. (1999) Mucolipidosis type IV: the origin of the disease in the Ashkenazi Jewish population. Eur. J. Hum. Genet. 7, 496-498
13. Zeevi, D.A., Frumkin, A. and Bach, G. (2007) TRPML and lysosomal function. Biochim. Biophys. Acta 1772, 851-858
14. Bargal, R., Avidan, N., Olender, Z., Ben Asher, E., Zeigler, M., Raas-Rothschild, A., Frumkin, A., Ben Yosef, O, Lancet, D. and Bach, G. (2001) Mucolipidosis type IV: novel mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population. Hum. Mutat. 17, 397-402
15. Bach, G., Webb, M.B.T., Bargal, R., Zeigler, M. and Ekstein, J. (2005) The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations. Hum. Mutat. 26, 591-596
16. Bach, G., Zeigler, M. and Zlotogora, J. (2007) Prevention of lysosomal storage disorders in Israel. Mol. Genet. Metab. 90, 353-357
17. Merin, S., Livni, N., Berman, E.R. and Yatziv, S. (1975) Mucolipidosis IV: ocular systemic and ultrastructural findings. Invest. Ophthalmol. 14, 437-448
18. Newell, F.W., Matalon, R. and Meyers, S. (1975) A new mucolipidosis with psychomotor retardation, corneal clouding and retina degeneration. Am. J. Ophthalmol. 80, 440-449
19. Tellez-Nagel, I., Rapin, I., Iwamoto, T., Johnson, A.A., Norton, W.T. and Nitowsky, H. (1976) Mucolipidosis IV: clinical, ultrastructural, histochemical and chemical studies of a case, including a brain biopsy. Arch. Neurol. 33, 828-835
20. Goebel, H.H., Kohischutter, A. and Lenard, H.G. (1982) Morphological and chemical biopsy findings in mucolipidosis IV. Clin. Neuropathol. 1, 73-82
21. Folkerth, R.D., Alroy, J., Lomakina, I., Skutelsky, E., Raghavan, S.S. and Kolodny, E.H. (1995) Mucolipidosis IV: morphology and histochemistry of an autopsy case. J. Neuropathol. Exp. Neurol. 54, 154-164
22. Goldin, E., Blanchette-Mackie, E.J., Dwyer, N.K., Pentchev, P.G. and Brady, R.O. (1995) Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent. Pediat. Res. 37, 687-692
23. Bargal, R. and Bach, G. (1997) Mucolipidosis type IV: abnormal transport of lipids to the lysosomes. J. Inherit. Metab. Dis. 20, 625-632
24. Chen, C.S., Bach, G. and Pagano, R.E. (1998) Abnormal transport along the lysosomal pathway in mucolipidosis type IV disease. Proc. Natl. Acad. Sci. U.S.A. 95, 6373-6378
25. Jansen, S.M., Groener, J.E.M., Bax, W. and Poorthuis, B.J.H.M. (2001) Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis. J. Inherit. Metab. Dis. 24, 577-586
26. Pryor, P.R., Reimann, F., Gribble, F.M. and Luzio, J.P. (2006) Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic 7, 1388-1398
27. Pacheco, C.D. and Lieberman, A.P. (2008) The pathogenesis of Niemann-Pick type C disease: a role for autophagy. Expert Rev. Mol. Med. 10, e26
28. Karten, B., Peake, K.B. and Vance, J.E. (2009) Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1- deficient mammalian cells. Biochim. Biophys. Acta 1791, 659-670
29. Voelker, D.R. (2009) Genetic and biochemical analysis of non-vesicular lipid traffic. Annu. Rev. Biochem. 78, 827-856
30. Tang, Y., Li, H. and Liu, J.P. (2010) Niemann-Pick disease type C: from molecule to clinic. Clin. Exp. Pharmacol. Physiol. 37, 132-140
31. Kiselyov, K., Jennings, J.J., Rbaibi, Y. and Chu, C.T. (2007) Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 3, 259-262
32. Vergarajauregui, S., Connelly, P.S., Daniels, M.P. and Puertollano, R. (2008) Autophagic dysfunction in mucolipidosis type IV patients. Hum. Mol. Genet. 17, 2723-2737
33. Venugopal, B., Mesires, N.T., Kennedy, J.C., Curcio-Morelli, C., Laplante, J.M., Dice, J.F. and Sluagenhaupt, S.A. (2009) Chaperone-mediated autophagy is defective in mucolipidosis type IV. J. Cell. Physiol. 219, 344-353
34. Nilius, B. and Voets, T. (2005) TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflügers Arch. 451, 1-10
35. Montell, C. (2005) The TRP superfamily of cation channels. Sci. STKE 272, re3
36. Micsenyi, M.C., Dobrenis, K., Stephney, G., Pickel, J., Vanier, M.T., Slaugenhaupt, S.A. and Walkley, S.U. (2009) Neuropathology of the Mcoln1-/- knockout mouse model of mucolipidosis type IV. J. Neuropathol. Exp. Neurol. 68, 125-135
37. Fares, H. and Greenwald, I. (2001) Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin 1 homolog. Nat. Genet. 28, 64-68
38. Treusch, S., Knuth, S., Slaugenhaupt, S.A., Goldin, E., Grant, B.D. and Fares, H. (2004) Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosomal biogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 4483-4488
39. Schaheen, L., Dang, H. and Fares, H. (2006) Basis of lethality in C. elegans lacking CUP-5, the mucolipidosis type IV orthologue. Dev. Biol. 293, 382-391
40. Schaheen, L., Patton, G. and Fares, H. (2006) Suppression of the CUP-5 mucolipidosis type IV related lysosomal dysfunction by the inactivation of an ABC transporter in C. elegans. Development 133, 3939-3948
41. Venkatachalam, K., Long, A.A., Elsaesser, R., Nikolaeva, D., Broadie, K. and Montell, C. (2008) Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells. Cell 135, 838-851
42. LaPlante, J.M., Falardeau, J., Sun, M., Kanazirska, M., Brown, E.M., Slaugenhaupt, S.A. and Vassilev, P.M. (2002) Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 532, 183-187
43. 2+-dependent membrane trafficking in mucolipidosis IV. Biochem. Biophys. Res. Commun. 322, 1384-1391
44. Cantiello, H.F., Montalbetti, N., Goldmann, W.H., Raychowdhury, M.K., Gonzalez-Perrett, S., Timpanaro, G.A. and Chasan, B. (2005) Cation channel activity of mucolipin-1: the effect of calcium. Pflügers Arch. 451, 304-312
45. Piper, R.C. and Luzio, J.P. (2004) CUPpling calcium to lysosomal biogenesis. Trends Cell Biol. 14, 471-473
46. Manzoni, M., Monti, E., Bresciani, R., Bozzato, A., Barlati, S., Bassi, M.T. and Borsani, G. (2004) Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization. FEBS Lett. 567, 219-224
47. Vergarajauregui, S. and Puertollano, R. (2006) Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes. Traffic 7, 337-353
48. Miedel, M.T., Weixel, K.M., Bruns, J.R., Traub, L.M. and Weisz, O.A. (2006) Posttranslational cleavage and adaptor protein complex-dependent trafficking of mucolipin-1. J. Biol. Chem. 281, 12751-12759
49. Soyombo, A.A., Tjon-Kon-Sang, S., Raibabi, Y., Bashllari, E., Bisceglia, J., Muallem, S. and Kiselyov, K. (2006) TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J. Biol. Chem. 280, 7294-7301
50. Venkatachalan, K., Hoffmann, T. and Montel, C. (2006) Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1. J. Biol. Chem. 281, 17517-17527
51. 2+ in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149, 1053-1062
52. Puertollano, R. and Kisselyov, K. (2009) TRPMLs: in sickness and in health. Am. J. Physiol. Renal. Physiol. 296, F1245-F1254
53. 2+ release channel from liver lysosomes of rats. J. Biol. Chem. 282, 25259-25269
54. Raychowdhury, M.K., Gonzalez-Perrett, S., Montalbetti, N., Timpanaro, G.A., Chasan, B., Goldmann, W.H., Stahl, S., Cooney, A., Goldin, E. and Cantiello, H.F. (2004) Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum. Mol. Genet. 13, 617-627
55. Dong, X.P., Cheng, X., Mills, E., Delling, M., Wang, F., Kurz, T and Xu, H. (2008) The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455, 992-996
56. Di Palma, F., Belyantseva, I.A., Kim, H.J., Vogt, T.F., Kachar, B. and Noben-Trauth, K. (2002) Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc. Natl. Acad. Sci. U.S.A. 99, 14994-14999
57. Karacsonyi, C., Miguel, A.S. and Puertollano, R. (2007) Mucolipin-2 localizes to the Arf6 associated pathway and regulates recycling of GPI-Aps. Traffic 8, 1404-1414
58. Nagata, K., Zheng, L., Madathany, T., Castiglioni, A.J., Bartles, J.R. and Garcia-Anoveros, J. (2008) The varitint-waddler (Va) deafness mutation in TRPML3 generates constitutive,inward rectifying currents and causes cell degeneration. Proc. Nat. Acad. Sci. U.S.A. 105, 353-358
59. Atiba-Davies, M. and Noben-Trauth, K. (2007) TRPML3 and hearing loss in the varitint-waddler mouse. Biochim. Biophys. Acta 1772, 1028-1031
60. Xu, H., Delling, M., Li, L., Dong, X. and Clapham, D.E. (2007) Activating mutation in a mucolipin transient receptor potential channel leads to melanocytes loss in varitint-waddler mice. Proc. Natl. Acad. Sci. U.S.A. 104, 18321-18326
61. van Aken, A.F., Atiba-Davies, M., Marcotti, W., Goodyear, R.J., Bryant, J.E., Richardson, G.P., Noben-Trauth, K. and Kros, C.J. (2008) TRPML3 mutations cause impaired mechano-electrical transduction and depolarization by an inward-rectifier cation current in auditory hair cells of varitint-waddler mice. J. Physiol. 586, 5403-5418
62. Kim, H.J., Li, Q., Tjon-Kon-Sang, S., So, I., Kiselyov, K. and Muallem, S. (2007) Gain of function mutation in TRPML3 causes the mouse varitint-waddler phenotype. J. Biol. Chem. 282, 36138-36142
63. Grimm, C., Cuajungco, M.P., van Aken, A.F., Schnee, M., Jörs, S., Kros, C.J., Ricci, A.J. and Heller, S (2007) Helix-breaking mutation in TRPML3 leads to constitutive activity underlying deafness in the varitint-waddler mouse. Proc. Natl. Acad. Sci. U.S.A. 104, 19583-19588
64. Grimm, C., Jörs, S. and Heller, S. (2009) Life and death of sensory hair cells expressing constitutively active TRPML3. J. Biol. Chem. 284, 13823-13831
65. Lev, S., Zeevi, D.A., Frumkin, A., Offen-Glasner, V., Bach, G. and Minke, B. (2010) Constitutive activity of the human TRPML2 channel induces cell degeneration. J. Biol. Chem. 285, 2771-2782
66. 2+ channel TRPML3 regulates membrane trafficking and autophagy. Traffic. 10, 1157-1167
67. Martina, J.A., Lelouvier, B. and Puertollano, R. (2009) The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway. Traffic 10, 1143-1156
68. Zeevi, D.A., Frumkin, A., Offen-Glaser, V., Kogot-Levin, A. and Bach, G. (2009) Potentially dynamic lysosomal role for the endogenous TRPML proteins. J. Pathol. 219, 153-162
69. Curcio-Morelli, C., Zhang, P., Venugopal, B., Charles, F.A., Browning, M.F., Cantiello, H.F. and Slaugenhaupt, S.A. (2010) Functional multimerization of mucolipin channel proteins. J. Cell. Physiol. 222, 328-335
70. 2+-dependent interactor of mucolipin-1. J. Biol. Chem. 284, 36357-36366